Hello, Fool! | Login | Signup | My Fool
Jan 9, 2009 8:54 PM ET | Feedback | Site Changes | Help
A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.
View All Commentary (ENDP)
Recs
MPOWERD (< 20) Submitted: 1/03/08 1:33 AM : Start Price: $26.59 ENDP Score: 19.27
I think this stock has excellent growth potential. Doctors are prescribing Opana and Opana ER more now that ever as an alternative to OxyContin for long term pain management.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK